Synergy between phenotypic modulation and ROS neutralization in reduction of inflammatory response of hypoxic microglia by using phosphatidylserine and antioxidant containing liposomes-Reference-Cited by-同舟云学术

Synergy between phenotypic modulation and ROS neutralization in reduction of inflammatory response of hypoxic microglia by using phosphatidylserine and antioxidant containing liposomes

Published:2016-01-04 Issue:3 Volume:27 Page:290-302
ISSN:0920-5063
Container-title:Journal of Biomaterials Science, Polymer Edition
language:en
Short-container-title:Journal of Biomaterials Science, Polymer Edition

Author:

Hosain Md Zahangir,Mori Takeshi,Kishimura Akihiro,Katayama Yoshiki

Funder

Ministry of Education, Culture, Sports, Science, and Technology

Publisher

Informa UK Limited

Subject

Biomedical Engineering,Biomaterials,Bioengineering,Biophysics

Link

http://www.tandfonline.com/doi/pdf/10.1080/10256018808623883

Reference57 articles.

1. Mechanisms, challenges and opportunities in stroke

2. Inflammatory mechanisms in ischemic stroke: role of inflammatory cells

3. The Harms and Benefits of Inflammatory and Immune Responses in Vascular Disease

4. Reperfusion-Induced Oxidative/Nitrative Injury to Neurovascular Unit After Focal Cerebral Ischemia

5. Inflammation in stroke and focal cerebral ischemia

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Improving outcomes in intracerebral hemorrhage through microglia/macrophage-targeted IL-10 delivery with phosphatidylserine liposomes;Biomaterials;2023-10

2. The Potentials of Melatonin in the Prevention and Treatment of Bacterial Meningitis Disease;Molecules;2021-03-05

3. Neuroprotective phosphatidylserine liposomes alleviate depressive-like behavior related to stroke through neuroinflammation attenuation in the mouse hippocampus;Psychopharmacology;2021-02-11

4. Combination therapy of phosphatidylserine liposome with cyclosporine A improves nephrotoxicity and attenuates delayed-type hypersensitivity response;Life Sciences;2021-01

5. Hybrid Pectin-Liposome Formulation against Multi-Resistant Bacterial Strains;Pharmaceutics;2020-08-14